FTRE
Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.42
−0.31%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$22.50
From 52W high−1.43%
Volume1.31M
Market cap$2.13B
P/E (TTM)—
P/S (TTM)0.8x
Div yield—
Key dataOct 19, 2026
Open
$22.50
From 52W high
−1.43%
Volume
1.31M
Market cap
$2.13B
ValuationView details →
P/E (Fwd)
22.1x
EV/EBITDA
37.9x
P/E (TTM)
—
RSI (14)
70.5
MomentumView details →
1D Return
−0.31%
YTD Return
+32.99%
SummaryUpdated Jun 1, 2026
Fortrea Holdings Inc. (NYSE:FTRE) is a contract research organization (CRO) that was spun off from Laboratory Corporation of America Holdings (LabCorp) in July 2023. The company was incorporated in 2023 and is headquartered in Durham, North Carolina. As a newly independent public company, Fortrea provides comprehensive clinical research services to pharmaceutical, biotechnology, and medical device companies worldwide, helping them navigate the complex process of bringing new treatments and medical devices to market.
Similar companies
Latest newsMore news →
Fortrea Holdings Inc. completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials LLC.7h agoFortrea announced it will release its third quarter 2026 financial results before market open on October 29, 2026, and host a conference call that day at 8:00 a.m. ET.15d ago